Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Salah A Abdel-Aziz

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Journal of Enzyme Inhibition and Medicinal Chemistry|April 14, 2016
Synthesis, cyclooxygenase inhibition and anti-inflammatory evaluation of new 1,3,5-triaryl-4,5-dihydro-1H-pyrazole derivatives possessing methanesulphonyl pharmacophoreKhaled R A Abdellatif, Mohammed T Elsaady, Salah A Abdel-Aziz, et al.
Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society|March 26, 2016
Design and synthesis of some substituted thiazolo[3,2-a]pyrimidine derivatives of potential biological activitiesSamia G Abdel Moty, Mostafa A Hussein, Salah A Abdel Aziz, et al.
European Journal of Medicinal Chemistry|August 27, 2021
Molecular hybrids: A five-year survey on structures of multiple targeted hybrids of protein kinase inhibitors for cancer therapyOsama M Soltan, Mai E Shoman, Salah A Abdel-Aziz, et al.
Bioorganic Chemistry|October 7, 2019
Design, synthesis and biological evaluation of some new 1,3,4-thiadiazine-thiourea derivatives as potential antitumor agents against non-small cell lung cancer cellsFatma A F Ragab, Salah A Abdel-Aziz, Marwa Kamel, et al.
European Journal of Medicinal Chemistry|July 2, 2017
Design, synthesis and anticancer activity of new monastrol analogues bearing 1,3,4-oxadiazole moietyFatma A F Ragab, Sahar M Abou-Seri, Salah A Abdel-Aziz, et al.
Archiv Der Pharmazie|March 5, 2024
A decade's overview of 2-aminothiophenes and their fused analogs as promising anticancer agentsDonia G Darwish, Hany A M El-Sherief, Salah A Abdel-Aziz, et al.
Archiv Der Pharmazie|June 20, 2019
Towards anticancer fluoroquinolones: A review articleMohamed A A Abdel-Aal, Salah A Abdel-Aziz, Montaser Sh A Shaykoon, et al.
ACS Omega|December 2, 2024
Synthesis and Antimicrobial Evaluation of New 1,2,4-Triazolo[1,5-<i>a</i>]pyrimidine-Based Derivatives as Dual Inhibitors of Bacterial DNA Gyrase and DHFRLamya H Al-Wahaibi, Safwat M Rabea, Mohamed A Mahmoud, et al.
Bioorganic & Medicinal Chemistry Letters|September 22, 2025
Design, synthesis, and biological evaluation of novel 1,5-diarylpyrazole carboxamides with dual inhibition of EGFR and COX-2 for the treatment of cancer and inflammatory diseasesOsama M Soltan, Salah A Abdel-Aziz, Kamal S Abdelrahman, et al.
Pharmacological Reports : PR|March 12, 2021
JNK signaling as a target for anticancer therapyKamal S Abdelrahman, Heba A Hassan, Salah A Abdel-Aziz, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Journal of Enzyme Inhibition and Medicinal Chemistry|April 14, 2016
Synthesis, cyclooxygenase inhibition and anti-inflammatory evaluation of new 1,3,5-triaryl-4,5-dihydro-1H-pyrazole derivatives possessing methanesulphonyl pharmacophoreKhaled R A Abdellatif, Mohammed T Elsaady, Salah A Abdel-Aziz, et al.
Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society|March 26, 2016
Design and synthesis of some substituted thiazolo[3,2-a]pyrimidine derivatives of potential biological activitiesSamia G Abdel Moty, Mostafa A Hussein, Salah A Abdel Aziz, et al.
European Journal of Medicinal Chemistry|August 27, 2021
Molecular hybrids: A five-year survey on structures of multiple targeted hybrids of protein kinase inhibitors for cancer therapyOsama M Soltan, Mai E Shoman, Salah A Abdel-Aziz, et al.
Bioorganic Chemistry|October 7, 2019
Design, synthesis and biological evaluation of some new 1,3,4-thiadiazine-thiourea derivatives as potential antitumor agents against non-small cell lung cancer cellsFatma A F Ragab, Salah A Abdel-Aziz, Marwa Kamel, et al.
European Journal of Medicinal Chemistry|July 2, 2017
Design, synthesis and anticancer activity of new monastrol analogues bearing 1,3,4-oxadiazole moietyFatma A F Ragab, Sahar M Abou-Seri, Salah A Abdel-Aziz, et al.
Archiv Der Pharmazie|March 5, 2024
A decade's overview of 2-aminothiophenes and their fused analogs as promising anticancer agentsDonia G Darwish, Hany A M El-Sherief, Salah A Abdel-Aziz, et al.
Archiv Der Pharmazie|June 20, 2019
Towards anticancer fluoroquinolones: A review articleMohamed A A Abdel-Aal, Salah A Abdel-Aziz, Montaser Sh A Shaykoon, et al.
ACS Omega|December 2, 2024
Synthesis and Antimicrobial Evaluation of New 1,2,4-Triazolo[1,5-<i>a</i>]pyrimidine-Based Derivatives as Dual Inhibitors of Bacterial DNA Gyrase and DHFRLamya H Al-Wahaibi, Safwat M Rabea, Mohamed A Mahmoud, et al.
Bioorganic & Medicinal Chemistry Letters|September 22, 2025
Design, synthesis, and biological evaluation of novel 1,5-diarylpyrazole carboxamides with dual inhibition of EGFR and COX-2 for the treatment of cancer and inflammatory diseasesOsama M Soltan, Salah A Abdel-Aziz, Kamal S Abdelrahman, et al.
Pharmacological Reports : PR|March 12, 2021
JNK signaling as a target for anticancer therapyKamal S Abdelrahman, Heba A Hassan, Salah A Abdel-Aziz, et al.
Pageof 3